Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Skull

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43925   clinical trials with a EudraCT protocol, of which   7306   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    43 result(s) found for: Skull. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2022-000680-49 Sponsor Protocol Number: MATRIx1.0 Start Date*: 2022-12-13
    Sponsor Name:AZIENDA SOCIO SANITARIA TERRITORIALE MONZA (ASST-MONZA)
    Full Title: Mesenchymal stromal cells for traumatic brain injury. A multicenter, double blind, randomized, placebo-controlled phase II trial
    Medical condition: Severe traumatic brain injury
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004863 10032349 Other open skull fracture with intracranial injury LLT
    20.0 100000004863 10032350 Other open skull fracture with intracranial injury of other and unspecified nature LLT
    20.0 100000004863 10009630 Closed fracture of vault of skull with intercranial injury of other and unspecified nature LLT
    20.0 100000004863 10009631 Closed fracture of vault of skull with intracranial injury LLT
    20.0 100000004863 10009648 Closed skull fracture with intracranial injury of other and unspecified nature LLT
    20.0 100000004863 10009512 Closed fracture of base of skull with intracranial injury LLT
    20.0 100000004863 10031756 Other closed skull fracture with intracranial injury LLT
    20.0 100000004863 10030657 Open fracture of vault of skull with intracranial injury LLT
    20.0 100000004863 10030658 Open fracture of vault of skull with intracranial injury of other and unspecified nature LLT
    20.0 100000004863 10030666 Open fractures involving skull or face with other bones, with intracranial injury LLT
    20.0 100000004863 10017263 Fracture of vault of skull, closed with intracranial injury LLT
    20.0 100000004863 10031757 Other closed skull fracture with intracranial injury of other and unspecified nature LLT
    20.0 100000004863 10009636 Closed fractures involving skull or face with other bones, with intracranial injury LLT
    20.0 100000004852 10042327 Subarachnoid, subdural, and extradural haemorrhage, following injury LLT
    20.0 100000004852 10031590 Other and unspecified intracranial hemorrhage following injury LLT
    20.0 100000004852 10031587 Other and unspecified intracranial haemorrhage following injury LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2015-003806-18 Sponsor Protocol Number: IC2014-16 Start Date*: 2016-03-24
    Sponsor Name:INSTITUT CURIE
    Full Title: IMPROVEMENT OF LOCAL CONTROL IN SKULL BASE AND SPINE CHORDOMAS TREATED BY SURGERY AND PROTONTHERAPY TARGETING HYPOXIC CELLS REVEALED BY POSITRON EMISSION TOMOGRAPHY NITROIMIDAZOLE ([18F]FAZA) PET/C...
    Medical condition: Chordomas of the skull base, spine and sacrum
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-013056-71 Sponsor Protocol Number: TC-2402-038-SP Start Date*: 2010-03-10
    Sponsor Name:Takeda Pharma A/S
    Full Title: TachoSil versus current practice in dura sealing techniques for the prevention of post-operative cerebrospinal fluid (CSF) leaks in patients undergoing skull base surgery: An open label, randomised...
    Medical condition: Skull base surgery for the prevention of postoperative cerebrospinal fluid (CSF) leaks
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10067908 Neurosurgery PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: BE (Completed) FR (Completed) FI (Prematurely Ended) SE (Completed) DE (Completed) NL (Completed) GR (Completed) ES (Completed) AT (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2018-002620-17 Sponsor Protocol Number: 18-513 Start Date*: 2019-01-08
    Sponsor Name:Portola Pharmaceuticals, Inc
    Full Title: A PHASE 4 RANDOMIZED CLINICAL TRIAL OF ANDEXANET ALFA [ANDEXANET ALFA FOR INJECTION] IN ACUTE INTRACRANIAL HEMORRHAGE IN PATIENTS RECEIVING AN ORAL FACTOR XA INHIBITOR
    Medical condition: Oral FXa inhibitor-treated patients with acute intracranial bleeding.
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10075279 Anticoagulant reversal therapy LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) GB (GB - no longer in EU/EEA) AT (Completed) BE (Completed) NL (Completed) ES (Prematurely Ended) GR (Completed) CZ (Completed) LV (Completed) FI (Prematurely Ended) NO (Prematurely Ended) LT (Prematurely Ended) PL (Completed) PT (Prematurely Ended) DK (Prematurely Ended) IT (Prematurely Ended) HU (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-006089-14 Sponsor Protocol Number: MIV-PK/PD-90255 Start Date*: 2008-02-21
    Sponsor Name:Neus Fabregas Julia - Hospital Clinic de Barcelona
    Full Title: Farmacocinética y farmacodinámica del mivacurio en los pacientes tratados de forma crónica con anticomiciales
    Medical condition: Anestesia en pacientes sometidos a neurocirugía
    Disease: Version SOC Term Classification Code Term Level
    9.1 10011322 Craniotomy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-003359-39 Sponsor Protocol Number: ZEST Start Date*: 2014-01-14
    Sponsor Name:Fundació Clínic per a la Recerca Biomèdica
    Full Title: Bisphosphonate Therapy with Zoledronic acid or Tenofovir Switching to Improve Low Bone Mineral Density in HIV-Infected Adults
    Medical condition: low bone mineral density - HIV
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004862 10068341 HIV-1 infection LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-004360-22 Sponsor Protocol Number: Huntiam Start Date*: 2021-10-22
    Sponsor Name:Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (Ciberned)
    Full Title: MULTI-TECHNICAL TEST ON THE USE OF COMBINED THERAPY OF THEMIN AND BIOTINE IN PATIENTS WITH HUNTINGTON'S DISEASE
    Medical condition: Huntington´s disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10010331 - Congenital, familial and genetic disorders 10070668 Huntington's disease PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-002776-83 Sponsor Protocol Number: Neuro-Ox-2018 Start Date*: 2018-04-17
    Sponsor Name:Bispebjerg Hospital
    Full Title: Neuro-Ox-2018: Assessment of cerebral oxygenation under three clinically relevant conditions
    Medical condition: Patients undergoing neurosurgery
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004865 10053764 Brain tumor operation LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2018-001974-76 Sponsor Protocol Number: MK-3475-630 Start Date*: 2019-01-16
    Sponsor Name:Merck Sharp & Dohme LLC
    Full Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Adv...
    Medical condition: Resectable high-risk locally advanced cutaneous squamous cell carcinoma (LA cSCC)
    Disease: Version SOC Term Classification Code Term Level
    21.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10041823 Squamous cell carcinoma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NO (Trial now transitioned) GB (GB - no longer in EU/EEA) DE (Trial now transitioned) FR (Ongoing) PT (Ongoing) HU (Trial now transitioned) ES (Ongoing) GR (Trial now transitioned) IE (Trial now transitioned) IT (Ongoing) PL (Trial now transitioned) RO (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2017-002978-39 Sponsor Protocol Number: Ambulante_Geburtseinleitung Start Date*: 2019-04-25
    Sponsor Name:Medizinische Universität Graz
    Full Title: Women's satisfaction with outpatient double-balloon catheter versus inpatient dinoprostone vaginal insert for induction of labour
    Medical condition: Induction of labour
    Disease: Version SOC Term Classification Code Term Level
    20.0 10042613 - Surgical and medical procedures 10052856 Labour induction PT
    Population Age: Adults Gender: Female
    Trial protocol: AT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-003381-33 Sponsor Protocol Number: EMR-62202-717 Start Date*: 2007-08-30
    Sponsor Name:Institute of Oncology Ljubljana
    Full Title: Induction chemotherapy followed by chemoradiation with cetuximab and cisplatin for inoperable squamous cell carcinoma of the head and neck.
    Medical condition: Inoperable squamous cell carcinoma of the head and neck.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SI (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-003072-39 Sponsor Protocol Number: NTUH-AADC-011 Start Date*: 2019-10-09
    Sponsor Name:National Taiwan University Hospital
    Full Title: A Clinical Trial for Treatment of Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion
    Medical condition: Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
    Disease:
    Population Age: Children, Under 18 Gender: Male, Female
    Trial protocol: Outside EU/EEA
    Trial results: View results
    EudraCT Number: 2018-004364-66 Sponsor Protocol Number: BMR111-208 Start Date*: 2019-10-22
    Sponsor Name:BioMarin Pharmaceutical Inc.
    Full Title: A Phase 2 Open-Label Long-Term Extension Study to Evaluate the Safety and Efficacy of BMN 111 in Children with Achondroplasia
    Medical condition: Achondroplasia
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004850 10000452 Achondroplasia LLT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2020-002205-26 Sponsor Protocol Number: FNUSA-2020-01 Start Date*: 2020-06-18
    Sponsor Name:Fakultní nemocnice u sv. Anny v Brně
    Full Title: [68Ga] -SomaKIT-TOC PET / CT in postoperative evaluation of meningioma residues in the cranial base area
    Medical condition: evaluation of meningioma residues in the cranial base area
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10027191 Meningioma PT
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10029104 Neoplasms benign, malignant and unspecified (incl cysts and polyps) SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2011-000392-14 Sponsor Protocol Number: 1200.131 Start Date*: 2011-07-27
    Sponsor Name:Boehringer Ingelheim Limited
    Full Title: LUX-Head & Neck 2 A randomised, double-blind, placebo-controlled, phase III study to evaluate the efficacy and safety of afatinib (BIBW 2992) as adjuvant therapy after chemoradiotherapy in primary...
    Medical condition: Loco-regionally advanced head and neck squamous cell carcinoma with no evidence of disease after chemo-radiotherapy
    Disease: Version SOC Term Classification Code Term Level
    18.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10060121 Squamous cell carcinoma of head and neck PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) ES (Prematurely Ended) BE (Completed) FR (Prematurely Ended) NL (Prematurely Ended) DE (Completed) FI (Prematurely Ended) GR (Prematurely Ended) AT (Prematurely Ended) SE (Prematurely Ended) IT (Completed) CZ (Prematurely Ended) DK (Prematurely Ended) PT (Prematurely Ended) HU (Prematurely Ended) PL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-002174-30 Sponsor Protocol Number: B3D-US-GHCV Start Date*: 2005-09-09
    Sponsor Name:Eli Lilly and Company
    Full Title: The Use of Nuclear Scintigraphy to Evaluate the Anabolic Effects of Teriparatide on the Skeleton in Postmenopausal Women in Osteoporosis
    Medical condition: Oesteoporosis
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-006913-26 Sponsor Protocol Number: FLACC2008 Start Date*: 2009-01-20
    Sponsor Name:Departement of orthopaedic surgery, Århus Sygehus
    Full Title: Postoperative smerter efter bækkenosteotomi med lokal infiltrationsanalgesi hos børn med cerebral parese. Et prospektivt, randomiseret og dobbeltblindet studie.
    Medical condition: cerebral parese
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009445 Closed frac of bos with intcran inj of oth and unspec nature, with moderate loc LLT
    9.1 10040348 Serum noradrenaline increased LLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2020-003671-17 Sponsor Protocol Number: NANOPRO Start Date*: 2021-02-15
    Sponsor Name:Centre François Baclesse
    Full Title: Nanoparticle reirradiation and hypofractionated protontherapy of pan-tumor relapse: non-randomized phase II study.
    Medical condition: recurrent tumors
    Disease: Version SOC Term Classification Code Term Level
    20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10038111 Recurrent cancer PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2019-000959-14 Sponsor Protocol Number: 29BRC18.0262 Start Date*: 2021-03-16
    Sponsor Name:CHRU de Brest
    Full Title: The NIPA study: A randomized double-blind control clinical trial Naloxegol administration to prevent opioids induced gastrointestinal motility disturbance in brain Injured PAtients.
    Medical condition: Prevent opioids induced gastrointestinal motility disturbance in brain Injured Patients.
    Disease: Version SOC Term Classification Code Term Level
    20.1 10017947 - Gastrointestinal disorders 10061173 Gastrointestinal motility disorder PT
    21.1 10029205 - Nervous system disorders 10042316 Subarachnoid haemorrhage PT
    20.0 100000004863 10078809 Skull trauma LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-000096-21 Sponsor Protocol Number: NXDC-MEN-301 Start Date*: 2020-08-04
    Sponsor Name:NX Development Corp.
    Full Title: A Phase 3 Multicenter Study of Gleolan (Aminolevulinic Acid Hydrochloride) to Enhance Visualization of Tumor in Patients with Newly Diagnosed or Recurrent Meningiomas
    Medical condition: Meningioma
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10027191 Meningioma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) AT (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sat Jun 15 22:24:14 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA